A new agent for the treatment of lymphoid neoplasias

The present invention claims the use of a micro RNA (miR-28) for the treatment of mature B cell neoplasias, including Burkitt lymphoma (BL), diffuse large B cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). The patent application also claims different miRNA compositions, as well as compounds that mimic the miRNA activity of miR-28, including pharmaceutically acceptable carriers and the route of administration.

Número: 
EP15382249
Fecha de prioridad: 
Thursday, 14 May, 2015
Titulares: 
CNIC
Inventores: 
Almudena Rodríguez Ramiro, Nahikari Bartolomé izquierdo, Virginia García de Yébenes Mena
Documentación: